Safety and Efficacy of Semorinemab in Individuals With Prodromal to Mild Alzheimer Disease

2022179 citationsJournal Articlehybrid Open Access

Authors

ClinicalTrials.gov Identifier: NCT03289143.

Good health and well-being

Published in: JAMA Neurology

Volume 79, Issue 8, pp. 758-758

Field-Weighted Citation Impact: 19.84